Bayesian network structure for predicting local tumor recurrence in rectal cancer patients treated with neoadjuvant chemoradiation followed by surgery

被引:4
|
作者
Osong, Biche [1 ]
Masciocchi, Carlotta [2 ]
Damiani, Andrea [3 ]
Bermejo, Inigo [1 ]
Meldolesi, Elisa [2 ]
Chiloiro, Giuditta [2 ]
Berbee, Maaike [1 ]
Lee, Seok Ho [4 ]
Dekker, Andre [1 ]
Valentini, Vincenzo [2 ,3 ]
Gerard, Jean-Pierre [5 ]
Roedel, Claus [6 ]
Bujko, Krzysztof [7 ]
van de Velde, Cornelis [8 ]
Folkesson, Joakim [9 ]
Sainato, Aldo [10 ]
Glynne-Jones, Robert [11 ]
Ngan, Samuel [12 ]
Braendengen, Morten [13 ]
Sebag-Montefiore, David [14 ]
van Soest, Johan [1 ]
机构
[1] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Radiat Oncol MAASTRO, Med Ctr, Maastricht, Netherlands
[2] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy
[3] Univ Cattolica Sacro Cuore, Rome, Italy
[4] Gachon Univ, Coll Med, Gil Med Ctr, Dept Radiat Oncol, Incheon, South Korea
[5] Ctr Antoine Lacassagne, Dept Radiotherapy, Nice, France
[6] Goethe Univ Frankfurt, Dept Radiotherapy, Frankfurt, Germany
[7] M Sklodowska Curie Natl Res Inst Oncol, Dept Radiotherapy 1, Warsaw, Poland
[8] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands
[9] Uppsala Univ Hosp, Dept Surg, Uppsala, Sweden
[10] Pisa Univ, Dept Radiotherapy, Pisa, Italy
[11] Mt Vernon Canc Ctr, Dept Radiotherapy, Northwood, Middx, England
[12] Peter MacCallum Canc Ctr, Dept Radiat Oncol, Melbourne, Vic, Australia
[13] Oslo Univ Hosp, Dept Oncol, Oslo, Norway
[14] Univ Leeds, Leeds Inst Med Res, Leeds, W Yorkshire, England
关键词
Netherlands; ABSTRACT; PREOPERATIVE RADIOTHERAPY; SURVIVAL PREDICTION; RISK-FACTORS; NOMOGRAMS; RESECTION; MODELS;
D O I
10.1016/j.phro.2022.03.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Purpose: Tumor recurrence, a characteristic of malignant tumors, is the biggest concern for rectal cancer survivors. The epidemiology of the disease calls for a pressing need to improve healthcare quality and patient outcomes. Prediction models such as Bayesian networks, which can probabilistically reason under uncertainty, could assist caregivers with patient management. However, some concerns are associated with the standard approaches to developing these structures in medicine. Therefore, this study aims to compare Bayesian network structures that stem from these two techniques.Materials and Methods: A retrospective analysis was performed on 6754 locally advanced rectal cancer (LARC) patients enrolled in 14 international clinical trials. Local tumor recurrence at 2, 3, and 5-years was defined as the endpoints of interest. Five rectal cancer treating physicians from three countries elicited the expert structure. The algorithmic structure was inferred from the data with the hill-climbing algorithm. Structural performance was assessed with calibration plots and area under the curve values.Results: The area under the curve for the expert structure on the training and validation data was above 0.9 and 0.8, respectively, for all the time points. However, the algorithmic structure had superior predictive performance over the expert structure for all time points of interest.Conclusion: We have developed and internally validated a Bayesian networks structure from experts' opinions, which can predict the risk of a LARC patient developing a tumor recurrence at 2, 3, and 5 years. Our result shows that the algorithmic-based structures are more performant and less interpretable than expert based structures.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [31] MnSOD and GPx-1 polymorphisms in relation to local recurrence in patients with rectal cancer treated with chemoradiation.
    Gordon, MA
    Zhang, W
    Yang, DY
    Gil, J
    Yun, J
    Press, O
    Mallik, N
    Lenz, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 271S - 271S
  • [32] Impact of the distal resection margin on local recurrence after neoadjuvant chemoradiation and rectal excision for locally advanced rectal cancer
    Song, Seung Ho
    Park, Jun Seok
    Choi, Gyu-Seog
    Seo, An Na
    Park, Soo Yeun
    Kim, Hye Jin
    Lee, Sung-Min
    Yoon, Ghilsuk
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [33] Impact of the distal resection margin on local recurrence after neoadjuvant chemoradiation and rectal excision for locally advanced rectal cancer
    Seung Ho Song
    Jun Seok Park
    Gyu-Seog Choi
    An Na Seo
    Soo Yeun Park
    Hye Jin Kim
    Sung-Min Lee
    Ghilsuk Yoon
    Scientific Reports, 11
  • [34] Locally advanced rectal cancer treated with preoperative chemoradiation:: Analysis of factors predicting recurrence and survival
    Pimentel, P.
    Rosel, S.
    Roda, D.
    Bosch, A.
    Navan, S.
    Campos, S.
    Rodriguez, E.
    Faiz, O.
    Garcia-Granero, E.
    Cervantes, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 142 - 142
  • [35] The Use of Somatic Mutation Status in Predicting Response to Neoadjuvant Chemoradiation in Patients with Rectal Cancer
    Hill, M.
    Wong, J. K.
    Handorf, E.
    Yu, J.
    Farma, J. M.
    Meyer, J.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S104 - S104
  • [36] Neoadjuvant therapy for rectal cancer: Improved tumor response, local recurrence, and overall survival in nonanemic patients
    Box, B
    Lindsey, I
    Wheeler, JM
    Warren, BF
    Cunningham, C
    George, BD
    Mortensen, NJ
    Jones, AC
    DISEASES OF THE COLON & RECTUM, 2005, 48 (06) : 1153 - 1160
  • [37] Reply: Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer
    Bao, Yongxing
    Wang, Yang
    Hui, Zhouguang
    THORACIC CANCER, 2022, 13 (21) : 3101 - 3101
  • [38] Neutrophil to Lymphocyte Ratio: A Predictive Marker for Treatment Outcomes in Patients With Rectal Cancer Who Underwent Neoadjuvant Chemoradiation Followed by Surgery
    Jeon, Byong Ho
    Shin, Ui Sup
    Moon, Sun Mi
    Choi, Jung Il
    Kim, Mi-Sook
    Kim, Kie Hwan
    Sung, Se-Jin
    ANNALS OF COLOPROCTOLOGY, 2019, 35 (02) : 100 - 106
  • [39] Risk score model for predicting local control and survival in patients with rectal cancer treated with neoadjuvant chemoradiotherapy
    Catal, Tuba Kurt
    Can, Gunay
    Demirel, Ismail Fatih
    Ergen, Sefika Arzu
    Oksuz, Didem Colpan
    ONCOLOGY LETTERS, 2025, 29 (05)
  • [40] THE USE OF PERSONALIZED BIOMARKERS FOR THE ASSESSMENT OF TUMOR RESPONSE AND DETERMINE FINAL MANAGEMENT IN RECTAL CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMORADIATION
    Carpinetti, P.
    Perez, R.
    Habr-Gama, A.
    Gama-Rodrigues, J.
    Donnard, E.
    Koyama, F.
    Bettoni, F.
    Parmigiani, R.
    Galante, P.
    Camargo, A.
    DISEASES OF THE COLON & RECTUM, 2014, 57 (05) : E243 - E244